Kingfisher Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Kingfisher Capital's GILD Position: Q3 2020 in Review
Kingfisher Capital sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 20,744 shares — an estimated $1.6M sold.
Kingfisher Capital first reported a position in GILD in Q1 2014 and held it in 19 quarters. The position peaked at $1.96M in Q3 2014. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Kingfisher Capital reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Kingfisher Capital sold 20,744 Gilead Sciences shares in Q3 2020, an estimated $1.6M.
- Kingfisher Capital first reported a position in Gilead Sciences in Q1 2014 and held it in 19 quarters.
- Kingfisher Capital's Gilead Sciences position peaked at $1.96M in Q3 2014.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Kingfisher Capital's 13F filing for Q3 2020, filed 12 Nov 2020.